Product logins

Find logins to all Clarivate products below.


Infusion Pumps | Market Insights | Europe | 2024

The European infusion pump market would be primarily driven by factors such as the growing demand of non-hospital settings, which stimulate the demand for disposable and electronic ambulatory pumps. The market is further driven by smart infusion pumps integrated with HCIT capabilities, and the adoption of innovative products like hybrid closed-loop insulin pumps that are priced at a premium. These high-end products, which are likely to be sold at a higher cost, are predicted to contribute to a modest growth over the forecast period.

This Medtech 360 Report offers thorough information and comprehensive analysis on the state of the infusion pump market in Europe from 2019 through 2032.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…